Showing results 1 to 20 of 32
next >
| Issue Date | Title | Author(s) |
| 2016 | Characteristic pollen source area and vertical pollen dispersal and deposition in a mixed coniferous and deciduous broad-leaved woodland in the Changbai mountains, northeast China | Zhang, Shengrui; Xu, Qinghai; Gaillard, Marie-Jose; Cao, Xianyong; Li, Jianyong; Zhang, Liyan; Li, Yuecong; Tian, Fang; Zhou, Liping; Lin, Fengyou; Yang, Xiaolan |
| 16-Oct-2023 | Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies | Song, Yuqin; Wu, Shang-Ju; Shen, Zhixiang; Zhao, Donglu; Chan, Thomas Sau Yan; Huang, Huiqiang; Qiu, Lugui; Li, Jianyong; Tan, Tran-der; Zhu, Jun; Song, Yongping; Huang, Wei-Han; Zhao, Weili; Liu, Herman Sung Yu; Xu, Wei; Chen, Naizhi; Ma, Jun; Chang, Cheng-Shyong; Tse, Eric Wai Choi |
| 2017 | Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study | Leng, Yun; Hou, Jian; Jin, Jie; Zhang, Mei; Ke, Xiaoyan; Jiang, Bin; Pan, Ling; Yang, Linhua; Zhou, Fang; Wang, Jianmin; Wang, Zhao; Liu, Li; Li, Wei; Shen, Zhixiang; Qiu, Lugui; Chang, Naibai; Li, Jianyong; Liu, Jing; Pang, Hongyan; Meng, Haitao; Wei, Peng; Jiang, Hua; Liu, Yan; Zheng, Xiangjun; Yang, Shifang; Chen, Wenming |
| 2019 | Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study | Wang, Ling; Wang, Ying; Hu, Jiong; Sun, Yuqian; Huang, He; Chen, Jing; Li, Jianyong; Ma, Jun; Li, Juan; Liang, Yingmin; Wang, Jianmin; Li, Yan; Yu, Kang; Hu, Jianda; Jin, Jie; Wang, Chun; Wu, Depei; Xiao, Yang; Huang, Xiaojun |
| Apr-2021 | Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study | Sun, Yuqian; Hu, Jiong; Huang, He; Chen, Jing; Li, Jianyong; Ma, Jun; Li, Juan; Liang, Yingmin; Wang, Jianmin; Li, Yan; Yu, Kang; Hu, Jianda; Jin, Jie; Wang, Chun; Wu, Depei; Xiao, Yang; Huang, Xiaojun |
| 2015 | Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study | Wu, Depei; Du, Xin; Jin, Jie; Xiao, Zhijian; Shen, Zhixiang; Shao, Zonghong; Li, Xiao; Huang, Xiaojun; Liu, Ting; Yu, Li; Li, Jianyong; Chen, Baoan; He, Guangsheng; Cai, Zhen; Liang, Hongchuang; Li, Jigang; Ruan, Changgeng |
| 2-Nov-2023 | Development and Validation of Deep Learning Model for Diagnosis and Subtypes Differentiation of Myeloproliferative Neoplasms Using Clinical Data and Digital Pathology | Wang, Rong; Shi, Zhongxun; Zhang, Yuan; Duan, Minghui; Xiao, Min; Chen, Suning; Huang, Jianyao; Hu, Xiaomei; Mei, Jinhong; Shen, Wenyi; Wei, Yongyue; Li, Jianyong |
| 2016 | Does High-Dose Cytarabine Cause More Fungal Infection in Patients With Acute Myeloid Leukemia Undergoing Consolidation Therapy A Multicenter, Prospective, Observational Study in China | Wang, Ling; Hu, Jiong; Sun, Yuqian; Huang, He; Chen, Jing; Li, Jianyong; Ma, Jun; Li, Juan; Liang, Yingmin; Wang, Jianmin; Li, Yan; Yu, Kang; Hu, Jianda; Jin, Jie; Wang, Chun; Wu, Depei; Xiao, Yang; Huang, Xiaojun |
| 2016 | Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China | Liu, Junru; Huang, He; Li, Yan; Liu, Lin; Li, Jianyong; Liu, Zhuogang; Lu, Jin; Ouyang, Jian; Song, Yongping; Zhou, Daobin; Ren, Hanyun; Ma, Jun; Wang, Chun; Yu, Li; Zhou, Jin; Wang, Jianmin; Xiao, Yang; Huang, Xiaojun; Li, Juan |
| Nov-2020 | Fluconazole is as effective as other anti-mold agents in preventing early invasive fungal disease after allogeneic stem cell transplantation: assessment of antifungal therapy in haematological disease in China | Sun, Yuqian; Hu, Jiong; Huang, He; Chen, Jing; Li, Jianyong; Ma, Jun; Li, Juan; Liang, Yingmin; Wang, Jianmin; Li, Yan; Yu, Kang; Hu, Jianda; Jin, Jie; Wang, Chun; Wu, Depei; Xiao, Yang; Huang, Xiaojun |
| 1-Jan-2021 | Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study | Zhang, Li; Meng, Li; Liu, Bingcheng; Zhang, Yanli; Zhu, Huanling; Cui, Jiuwei; Sun, Aining; Hu, Yu; Jin, Jie; Jiang, Hao; Zhang, Xi; Li, Yan; Liu, Li; Zhang, Wanggang; Liu, Xiaoli; Gu, Jian; Qiao, Jianhui; Ouyang, Guifang; Liu, Xin; Luo, Jianmin; Jiang, Ming; Xie, Xiaobao; Li, Jianyong; Zhao, Chunting; Zhang, Mei; Yang, Tonghua; Wang, Jianxiang |
| 2019 | Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety | Huang, Xiaojun; Jiang, Qian; Hu, Jianda; Li, Jianyong; Jin, Jie; Meng, Fanyi; Shen, Zhixiang; Liu, Ting; Wu, Depei; Wang, Jianmin; Wang, Jianxiang |
| 2017 | Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China | Huang, Xiao Jun; Liu, Kaiyan; Ritchie, David; Andersson, Borje; Lu, Jin; Hou, Jian; Burguera, Adolfo de la Fuente; Wang, JianXiang; Yeoh, Allen; Yan, Chenhua; Zhou, Daobin; Tan, Daryl; Kim, Dong Wook; Wu, Depei; Shpall, Elizabeth; Kornblau, Stephen; Neelapu, Sattava; Hongeng, Suradej; Li, Jianyong; Hu, Jiong; Zhang, Lian Sheng; Wang, Michael; Malhotra, Pankaj; Jiang, Qian; Qin, Yazhen; Wong, Raymond; Champlin, Richard; Hagemeister, Frederick; Westin, Jason; Iyer, Swaminathan; Mathews, Vikram; Wang, Yu; Hu, Yu; Xiao, Zhijian; Shao, Zonghong |
| 2012 | Homoharringtonine-Based Induction Regimens for Patients with De Novo Acute Myeloid Leukemia: A Multicenter Randomized Controlled Phase 3 Trial | Jin, Jie; Wang, Jianxiang; Chen, Feifei; Wu, Depei; Hu, Jiong; Zhou, Jianfeng; Hu, Jianda; Wang, Jianmin; Li, Jianyong; Huang, Maojun; Ma, Jun; Ji, Chunyan; Xu, Maoping; Yu, Kang; Ren, Hanyun; Zhou, Yuhong; Tong, Yin; Mi, Yingchang; Du, Xin; Chen, Baoan; Chen, Zhu; Chen, Sai-Juan |
| 2018 | Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia | Huang, Liang; Liu, Dan; Wang, Na; Ling, Shaoping; Tang, Yuting; Wu, Jun; Hao, Lingtong; Luo, Hui; Hu, Xuelian; Sheng, Lingshuang; Zhu, Lijun; Wang, Di; Luo, Yi; Shang, Zhen; Xiao, Min; Mao, Xia; Zhou, Kuangguo; Cao, Lihua; Dong, Lili; Zheng, Xinchang; Sui, Pinpin; He, Jianlin; Mo, Shanlan; Yan, Jin; Ao, Qilin; Qiu, Lugui; Zhou, Hongsheng; Liu, Qifa; Zhang, Hongyu; Li, Jianyong; Jin, Jie; Fu, Li; Zhao, Weili; Chen, Jieping; Du, Xin; Qing, Guoliang; Liu, Hudan; Liu, Xin; Huang, Gang; Ma, Ding; Zhou, Jianfeng; Wang, Qian-fei |
| 2015 | Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China | Sun, Yuqian; Huang, He; Chen, Jing; Li, Jianyong; Ma, Jun; Li, Juan; Liang, Yingmin; Wang, Jianmin; Li, Yan; Yu, Kang; Hu, Jianda; Jin, Jie; Wang, Chun; Wu, Depei; Xiao, Yang; Huang, Xiaojun |
| 2007 | An open-label study of pegylated liposomal doxorubicin, vincristine and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients in Chinese population | Shen, Yang; Shen, Zhixiang; Jiang, Bin; Hou, Jian; Zhan, Rong; Qiu, Lugui; Wu, Yongji; Jin, Jie; Li, Juan; Meng, Fanyi; Zou, Ping; Liu, Ting; Li, Jianyong; Wang, Chun; Wu, Depai; Ma, Jun |
| Jan-2023 | Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study | Xu, Wei; Zhou, Keshu; Wang, Tingyu; Yang, Shenmiao; Liu, Lihong; Hu, Yu; Zhang, Wei; Ding, Kaiyang; Zhou, Jianfeng; Gao, Sujun; Xu, Bing; Zhu, Zunmin; Liu, Ting; Zhang, Huilai; Hu, Jianda; Ji, Chunyan; Wang, Shunqing; Xia, Zhongjun; Wang, Xin; Li, Yan; Song, Yongping; Ma, Shuo; Tang, Xinran; Zhang, Bin; Li, Jianyong |
| 2013 | Phase 2 study of dasatinib in Chinese patients with chronic myeloid leukemia (CML) in chronic phase (CP) or advanced phase who are resistant to or intolerant of imatinib (IM) | Wang, Jianxiang; Huang, Xiaojun; Hu, Jianda; Li, Jianyong; Jin, Jie; Meng, Fanyi; Shen, Zhixiang; Liu, Ting; Wu, Depei; Wang, Jianmin |
| 2018 | Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin's lymphoma: a randomized Phase 3 study | Zhu, Jun; Huang, Huiqiang; Chen, Huan; Zhang, Xi; Li, Zengjun; Wu, Depei; Zhou, Daobin; Song, Yongping; Hu, Yu; Liang, Yingmin; Ren, Hanyun; Huang, He; Li, Nainong; Chen, Hu; Hu, Jiong; Li, Jianyong; Meng, Robin; Wu, Junlong; Yu, Dong; Huang, Xiaojun |
